About the Institute
The IIT brings together scientists, clinicians and patients to gain novel insights into the underlying causes of disease. It combines the clinical excellence of the Royal Free London NHS Foundation Trust and the research excellence of UCL to deliver patient-focussed research.
Collaborative working between the University and NHS provides an opportunity for patients to be involved in research, which accelerates the development of new medicines.
The IIT is part of the UCL Division of Infection and Immunity and was developed in partnership between UCL, Royal Free London NHS Foundation Trust and the Royal Free Charity. We are an important part of the research strategy of the Academic Health Science Centre of UCL-Partners.
What we do
At the Institute of Immunity and Transplantation, we develop vaccines and therapies to boost the immune system in patients with cancer and chronic infections.
Research
Our research streams are contained within three clusters: immune therapy, immune tolerance and inherited diseases.
Study
Our students are tutored by world-class researchers on programmes developed with the UCL Division of Infection & Immunity.
People
A directory of academic, research and administrative staff at the UCL Institute of Immunity and Transplantation.
Pears Building
The Pears Building is a world-class research centre in Hampstead that brings together scientists, clinicians, patients, and the public in a stunning open-plan environment.
Contact us
The Institute of Immunity and Transplantation is situated in the Pears Building. We are next to the Royal Free Hospital, in Hampstead, north London.
Support our work
We need funding to ensure that our future research leads to new and more effective treatments for millions of people worldwide.
Donate nowPioneering research in immunotherapy and disease treatment
At the IIT, we examine how defects of the immune system lead to disease. We use this knowledge to develop new forms of immunotherapy.
We work towards vaccines, gene therapy and cell therapy to enhance immunity in patients with cancer and chronic infection, and to induce tolerance in transplant patients and in autoimmune diseases.
Our research groups are studying new therapies for cancer and autoimmune diseases. Take a look behind the scenes at the fascinating work we do in Hampstead, north London.
